About Helio Health Inc
Services
Type of Care
Substance use treatment
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Outpatient; Outpatient methadone/buprenorphine or naltrexone treatment; Regular outpatient treatment
Opioid Medications used in Treatment
Buprenorphine used in Treatment; Naltrexone used in Treatment
Type of Alcohol Use Disorder Treatment
This facility administers/prescribes medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment
In-network prescribing entity; Other contracted prescribing entity; No formal relationship with prescribing entity
Type of Opioid Treatment
Buprenorphine maintenance; Prescribes buprenorphine; Prescribes naltrexone; Relapse prevention with naltrexone; Lofexidine or Clonidine detoxification; Maintenance service with medically supervised withdrawal after stabilization
Pharmacotherapies
Acamprosate (Campral®); Disulfiram; Buprenorphine sub-dermal implant; Buprenorphine with naloxone; Buprenorphine without naloxone; Buprenorphine (extended-release, injectable); Naltrexone (oral); Naltrexone (extended-release, injectable); Lofexidine; Clonidine; Medication for mental disorders; Nicotine replacement; Non-nicotine smoking/tobacco cessation
Treatment Approaches
Anger management; Brief intervention; Cognitive behavioral therapy; Contingency management/motivational incentives; Motivational interviewing; Matrix Model; Relapse prevention; Substance use disorder counseling; Telemedicine/telehealth therapy; Trauma-related counseling
Facility Operation (e.g., Private, Public)
Private non-profit organization
License/Certification/Accreditation
State Substance use treatment agency
Payment/Insurance/Funding Accepted
Federal, or any government funding for substance use treatment programs; Medicare; Medicaid; Private health insurance; Cash or self-payment
Special Programs/Groups Offered
Adult women; Adult men; Clients with co-occurring mental and substance use disorders
Assessment/Pre-treatment
Comprehensive substance use assessment; Outreach to persons in the community; Screening for tobacco use; Screening for substance use
Testing
Breathalyzer or blood alcohol testing; Drug or alcohol urine screening; TB screening; Testing for Hepatitis C (HCV)
Transitional Services
Aftercare/continuing care; Discharge Planning; Naloxone and overdose education
Recovery Support Services
Mentoring/peer support
Education and Counseling Services
HIV or AIDS education, counseling, or support; Hepatitis education, counseling, or support; Health education services other than HIV/AIDS or hepatitis; Substance use disorder education; Smoking/vaping/tobacco cessation counseling; Individual counseling; Group counseling
Facility Smoking Policy
Smoking not permitted
Age Groups Accepted
Young Adults; Adults
Gender Accepted
Female; Male
Language Services
Sign language services for the deaf and hard of hearing
Facility Vaping Policy
Vaping not permitted
Ancillary Services
Case management service
Type of Care
Substance use treatment
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Outpatient; Outpatient methadone/buprenorphine or naltrexone treatment; Regular outpatient treatment
Opioid Medications used in Treatment
Buprenorphine used in Treatment; Naltrexone used in Treatment
Type of Alcohol Use Disorder Treatment
This facility administers/prescribes medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment
In-network prescribing entity; Other contracted prescribing entity; No formal relationship with prescribing entity
Type of Opioid Treatment
Buprenorphine maintenance; Prescribes buprenorphine; Prescribes naltrexone; Relapse prevention with naltrexone; Lofexidine or Clonidine detoxification; Maintenance service with medically supervised withdrawal after stabilization
Pharmacotherapies
Acamprosate (Campral®); Disulfiram; Buprenorphine sub-dermal implant; Buprenorphine with naloxone; Buprenorphine without naloxone; Buprenorphine (extended-release, injectable); Naltrexone (oral); Naltrexone (extended-release, injectable); Lofexidine; Clonidine; Medication for mental disorders; Nicotine replacement; Non-nicotine smoking/tobacco cessation
Treatment Approaches
Anger management; Brief intervention; Cognitive behavioral therapy; Contingency management/motivational incentives; Motivational interviewing; Matrix Model; Relapse prevention; Substance use disorder counseling; Telemedicine/telehealth therapy; Trauma-related counseling
Facility Operation (e.g., Private, Public)
Private non-profit organization
License/Certification/Accreditation
State Substance use treatment agency
Payment/Insurance/Funding Accepted
Federal, or any government funding for substance use treatment programs; Medicare; Medicaid; Private health insurance; Cash or self-payment
Special Programs/Groups Offered
Adult women; Adult men; Clients with co-occurring mental and substance use disorders
Assessment/Pre-treatment
Comprehensive substance use assessment; Outreach to persons in the community; Screening for tobacco use; Screening for substance use
Testing
Breathalyzer or blood alcohol testing; Drug or alcohol urine screening; TB screening; Testing for Hepatitis C (HCV)
Transitional Services
Aftercare/continuing care; Discharge Planning; Naloxone and overdose education
Recovery Support Services
Mentoring/peer support
Education and Counseling Services
HIV or AIDS education, counseling, or support; Hepatitis education, counseling, or support; Health education services other than HIV/AIDS or hepatitis; Substance use disorder education; Smoking/vaping/tobacco cessation counseling; Individual counseling; Group counseling
Facility Smoking Policy
Smoking not permitted
Age Groups Accepted
Young Adults; Adults
Gender Accepted
Female; Male
Language Services
Sign language services for the deaf and hard of hearing
Facility Vaping Policy
Vaping not permitted
Ancillary Services
Case management service
